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Beyond transcription, gene expression is potently controlled
through processes that affect pre-mRNA splicing and matura-
tion, as well as mRNA transport, turnover, storage, and
translation. These events are tightly regulated by two main
classes of trans-binding factors, RNA-binding proteins (RBPs)
and non-coding RNAs (ncRNAs) (Moore, 2005; Mattick and
Makunin, 2006). RBPs bind to target transcripts and inﬂuence
virtually all facets of post-transcriptional gene expression;
ncRNAs, particularly microRNAs (miRNAs), mainly lower the
translation and stability of target mRNAs (Keene, 2007; Bartel,
2009). As mRNAs transit through the cell, their association
with RBPs and miRNAs determines their recruitment to
cellular sites such as processing bodies (PBs), stress granules
(SGs), polysomes, the exosome, and the RNA-induced silen-
cing complex (RISC), each specialized in distinct aspects of
mRNA metabolism (Filipowicz et al, 2008). In this manner,
ribonucleoprotein (RNP) interactions directly affect the types,
location, and abundance of expressed proteins.
In a report published in Molecular Systems Biology,
Mukherjee et al (2009) use quantitative RNA dynamics to
present a fundamentally new approach to study global RNP
networks. The study bridges two key and reciprocal concepts
in post-transcriptional gene regulation. The ﬁrst is that each
individual mRNA is capable of associating with numerous
RBPs. Several studies have shown that RBPs can interact
combinatorially on a single mRNA and thereby alter its post-
transcriptional fate and ultimately the levels of expressed
protein; for example, an RBP can compete or cooperate with
another RBP for binding to a shared target mRNA, while
miRNAs can promote or prevent the action of RBPs on a given
mRNA (e.g., Lal et al, 2004; George and Tenenbaum, 2006;
Filipowicz et al, 2008). The second, that each RBPcan interact
with multiple mRNAs and jointly coordinate their post-
transcriptional outcome; as described in the post-transcrip-
tional regulatoryoperon(PTRO) model proposedbyKeeneand
Tenenbaum (2002). The PTRO model further postulates that
such mRNA subsets encode proteins that are functionally
related, such that an RBP can synchronize the production of
multiple proteins in speciﬁc metabolic or response pathways.
The past decade has witnessed immense progress in the
analysis of RNP interactions. The vast majority of studies have
focused on ‘single RBP-single mRNA’ associations, some of
them furthertrackingchanges inRNPcomposition inresponse
to particular stimuli. A minority of studies have assessed more
complex RNPs, comprising ‘single RBP-multiple mRNAs’; by
RNP immunoprecipitation followed by microarray analysis of
enriched mRNAs (the RIP chip method), RBPs were found to
associate with hundreds of mRNAs, many of them also targets
of other RBPs. However, the value of RIP chip analyses was
hampered by its ‘static’ nature: it provided a useful ‘snapshot’
of RNP interactions at a speciﬁc point in time, but no
information regarding previous or subsequent associations.
Accordingly, it has not yet been possible to integrate RNP
complexes within networks of interaction with other trans-
bindingfactorsorbiologicalprocesses,norhasitbeenpossible
to predict if they might be effectors of speciﬁc compounds.
The new report by Mukherjee et al overcomes some of these
barriers. By studying changes in RNP associations over time,
they have gained unique new insight into the biology of RNP
interactions. Their study focuses on the RNA-binding protein
HuR within the context of Tcell activation, ﬁne choices for this
proof-of-principle study, as many HuR target mRNAs are
known and several HuR-regulated processes (such as T-cell
activation) have been described. Statistical modeling of HuR
RIP chip experiments at different times after activating Jurkat
cells with phytohemagglutinin and phorbol ester led to several
important discoveries. Among the ﬁrst observations, the
mRNA subsets bound to HuR followed different interaction
patterns, with mRNA subsets associating progressively more
after activation, others progressively less, yet others transi-
ently increasing or decreasing their association. These results
are signiﬁcant because they provide the ﬁrst systematic
demonstration that the dissociation of an RBP from an mRNA
isatleastasprominentaneventasincreasedassociation.They
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features intrinsic to the mRNA itself, not only by the binding
properties of the RBP. This ﬁnding further suggests that
speciﬁc signature RNA motifs may exist among target mRNAs
which become dissociated from an RBP under speciﬁc
conditions, distinct from signature motifs in target mRNAs
which become associated with the same RBP.
Additional analysis revealed that many HuR-associated
mRNAs did not show increased abundance in activated Jurkat
cells. This discordance is important, as it further supports the
notion that HuR is not only an mRNA-stabilizing RBP—HuR’s
ﬁrst-identiﬁed and best-known function (Brennan and Steitz,
2001)—but also can have other post-transcriptional inﬂu-
ences, including translational regulation, as reported for
several target mRNAs (Hinman and Lou, 2008), and possibly
also subcellular transport or storage. There was also an
important concordance between the pathways that HuR was
reported to modulate in the Mukherjee report (e.g., cell
proliferation, Wnt signaling, T-cell activation) and the path-
ways that HuR target mRNAs were predicted to affect. By
comparing HuR target mRNAs and the targets of other RBPs,
the authors show that many mRNAs are amply shared with
some RBPs (e.g., TTP) but not with others (e.g. TIAR).
Similarly, numerous miRNAs were also predicted to interact
with HuR target mRNAs. Adding complexity to this rich
network of interactions, HuR target transcripts included
several mRNAs that encoded RBPs, in keeping with earlier
evidence that a handful of RBPs bound combinatorially to one
another’s mRNAs (Pullmann et al, 2007).
One of the most promising aspects of this approach is that
the dynamic HuR-mRNA associations can be scanned against
proﬁles of the Connectivity Map (CMAP), a large collection of
mRNA expression proﬁles collected from cell lines perturbed
by hundreds of bioactive small molecules (Lamb et al, 2006).
By correlating HuR query signatures with speciﬁc CMAP
proﬁles (Figure 1), Mukherjee et al (2009) identify several
drugs that are predicted to modulate HuR function, including
previously known compounds, such as inhibitors of histone
deacetylases. The discovery and validation of resveratrol as a
novel inhibitor of HuR function shows that HuR is an effector
of resveratrol action and demonstrates the power of this
methodology. Intriguingly, resveratrol—an anti-inﬂammatory
COX-2 inhibitor—has been suggested to exert an anti-aging
effect, possibly by activating sirtuin-1 (Lagouge et al, 2006),
which is a known HuR target mRNA (Abdelmohsen et al,
2007).
The ﬁeld of post-transcriptional regulation of gene expres-
sion is ripe to study similar RNP dynamics for hundreds of
other RBPs. It can thus be anticipated that the approach
described by Mukherjee et al (2009) will be extended to
achieve the pressing goal of identifying chemical modulators
of other RBPs and potentially ncRNAs. Such analyses are
bound to uncover other exciting mRNA networks and
implicate other regulatory factors, metabolic pathways, and
biological processes. To help organize the information
obtained from these studies, it is also vital to develop
methodologies to identify systematically the trans-binding
factors—RBPs and ncRNAs—that interact with a speciﬁc
mRNA; to maximize the information obtained, such tagged
mRNAs should also be tracked in a dynamic fashion. Other
critical knowledge will come from live microscopic imaging of
RNP complexes, so that their composition can be studied
together with their subcellular localization and the conditions
of individual cells. Though still rudimentary, the technologies
and computational resources to study these processes are
improving rapidly. The information gained from studying RNP
interaction networks will be highly complex, yet organized in
PTROs—beﬁtting of the versatile post-transcriptional pro-
cesses that ensure protein production in the proper concentra-
tion, subcellular locale, developmental stage, and triggering
simuli, to ensure that homeostasis is maintained in complex
cell-environment interactions.
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Figure 1 Schematic depiction of one of the applications of RNP dynamics.
Following RIP chip analysis for a speciﬁc RBP, the top enriched and depleted
mRNAs are compared against the CMAP database (Lamb et al, 2006).
The resulting comparison can be used to identify drugs that activate or inhibit
that RBP.
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